Related references
Note: Only part of the references are listed.Progress in emerging therapies for advanced prostate cancer
Stephane Oudard
CANCER TREATMENT REVIEWS (2013)
Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer
Sead Crnalic et al.
ACTA ORTHOPAEDICA (2012)
A transcriptional repressor co-regulatory network governing androgen response in prostate cancers
Kern Rei Chng et al.
EMBO JOURNAL (2012)
SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice
Fahad Zadjali et al.
FASEB JOURNAL (2012)
Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression
Justin M. Drake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cancer risk in hyperprolactinemia patients: a population-based cohort study
Katarina Berinder et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Tumor Expression of Human Growth Hormone and Human Prolactin Predict a Worse Survival Outcome in Patients with Mammary or Endometrial Carcinoma
Zheng-Sheng Wu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Global quantification of mammalian gene expression control
Bjoern Schwanhaeusser et al.
NATURE (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
The SOCS2 Ubiquitin Ligase Complex Regulates Growth Hormone Receptor Levels
Mattias Vesterlund et al.
PLOS ONE (2011)
Human Prostate Cancer Xenografts in lit/lit Mice Exhibit Reduced Growth and Androgen-Independent Progression
Kiyoshi Takahara et al.
PROSTATE (2011)
Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans
Jaime Guevara-Aguirre et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines
Honglin Chen et al.
ENDOCRINE-RELATED CANCER (2010)
An update on androgen deprivation therapy for prostate cancer
Nima Sharifi et al.
ENDOCRINE-RELATED CANCER (2010)
Ezrin mediates c-Myc actions in prostate cancer cell invasion
Y-C Chuan et al.
ONCOGENE (2010)
Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors
Vincent Rouet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Prostate cancer and acromegaly
Livia L. Correa et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2009)
Src as a therapeutic target in men with prostate cancer and bone metastases
Fred Saad
BJU INTERNATIONAL (2009)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
Cocoa Butter and Safflower Oil Elicit Different Effects on Hepatic Gene Expression and Lipid Metabolism in Rats
Carolina Gustavsson et al.
LIPIDS (2009)
SOCS2 Influences LPS Induced Human Monocyte-Derived Dendritic Cell Maturation
Jin Hu et al.
PLOS ONE (2009)
Mechanisms mediating androgen receptor reactivation after castration
Xin Yuan et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines
Miltiadis Paliouras et al.
BIOLOGICAL CHEMISTRY (2008)
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells
Shyh-Han Tan et al.
CANCER RESEARCH (2008)
Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg rat
Zhuohua Wang et al.
ENDOCRINOLOGY (2008)
Cell- and gene-specific regulation of primary target genes by the androgen receptor
Eric C. Bolton et al.
GENES & DEVELOPMENT (2007)
In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver
Oscar M. Vidal et al.
MOLECULAR ENDOCRINOLOGY (2007)
Androgen induction of prostate cancer cell invasion is mediated by ezrin
Yin-Choy Chuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3
Elisa Bergamin et al.
STRUCTURE (2006)
Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase
Alex N. Bullock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Evolution of the androgen receptor pathway during progression of prostate cancer
Peter J. M. Hendriksen et al.
CANCER RESEARCH (2006)
Socs2 and Elf5 mediate prolactin-induced mammary gland development
J Harris et al.
MOLECULAR ENDOCRINOLOGY (2006)
Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in the C3(1)/T antigen mouse
ZH Wang et al.
ENDOCRINOLOGY (2005)
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally et al.
CANCER CELL (2005)
Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence
HZ Li et al.
CLINICAL CANCER RESEARCH (2005)
Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis
XQ Ma et al.
CANCER RESEARCH (2005)
SOCS2 negatively regulates growth hormone action in vitro and in vivo
CJ Greenhalgh et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice
JL Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
High levels of circulating insulin-like growth factor-I increase prostate cancer risk: A prospective study in a population-based nonscreened cohort
P Stattin et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade
HZ Li et al.
CANCER RESEARCH (2004)
Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells
E Weiss-Messer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b)
CJ Greenhalgh et al.
MOLECULAR ENDOCRINOLOGY (2002)
Lack of Socs2 expression causes the high-growth phenotype in mice
S Horvat et al.
GENOMICS (2001)
Androgen receptor expression in prostate carcinoma cells suppresses α6β4 integrin-mediated invasive phenotype
L Bonaccorsi et al.
ENDOCRINOLOGY (2000)
Gigantism in mice lacking suppressor of cytokine signalling-2
D Metcalf et al.
NATURE (2000)
Share Paper
